Cite
MLA Citation
Anthony R. Mato et al.. “Outcomes of front‐line ibrutinib treated CLL patients excluded from landmark clinical trial.” American journal of hematology, vol. 93, no. 11, n.d., pp. 1394–1401. http://access.bl.uk/ark:/81055/vdc_100070819222.0x00003b